Bayesian Capital Management’s Gentex GNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNTX
AI
Bayesian Capital Management's GNTX Position: Q2 2026 in Review
Bayesian Capital Management sold out of Gentex (GNTX) in Q2 2026, closing a stake of 14,775 shares — an estimated $323K sold.
Bayesian Capital Management first reported a position in GNTX in Q4 2015 and held it in 16 quarters. The position peaked at $1.07M in Q4 2023. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.
- Bayesian Capital Management reported no remaining Gentex position as of Q2 2026 after selling out during the quarter.
- Bayesian Capital Management sold 14,775 Gentex shares in Q2 2026, an estimated $323K.
- Bayesian Capital Management first reported a position in Gentex in Q4 2015 and held it in 16 quarters.
- Bayesian Capital Management's Gentex position peaked at $1.07M in Q4 2023.
- 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.